| For: | Pan XP, Jiya BR, Wang F, Lan Z. Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis. World J Gastrointest Oncol 2023; 15(8): 1400-1411 [PMID: 37663938 DOI: 10.4251/wjgo.v15.i8.1400] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i8/1400.htm |
| Number | Citing Articles |
| 1 |
Xue Yang, Chunming Liu, Yuxi Lei, Zhi Liu, Bin Zhu, Dongchi Zhao. PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1443784
|
| 2 |
Linyuan Yu, Jinxing Qin, Mei Zhang, Yawen Gao, Yongli Zhao. Research Progress on the Anti-Liver Cancer Mechanism and Toxicity of Rhubarb Anthraquinone. Drug Design, Development and Therapy 2024; : 6089 doi: 10.2147/DDDT.S489377
|
| 3 |
Xianggang Gou, Zhongzheng Zhou, Yuehua Wang, Henye Yuan, Ziyao Wang, Jie Chen, Wei Yan, Haisheng Wang, Jia Yan. Integrative analyses of network pharmacology and bioinformatics reveal the synergistic antitumor effects of cantharidin and ginsenosides Rg3 on hepatocellular carcinoma. Biochemical Pharmacology 2026; 246: 117700 doi: 10.1016/j.bcp.2026.117700
|
| 4 |
Doralyn S. Dalisay, Chuckcris P. Tenebro, Edna M. Sabido, Angelica Faith L. Suarez, Melissa June V. Paderog, Rikka Reyes-Salarda, Jonel P. Saludes. Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies. Marine Drugs 2024; 22(3): 114 doi: 10.3390/md22030114
|
